Chris Leahy is a dedicated and highly effective finance leader known for his reliability, expertise, and collaborative approach. As Executive Director, Finance and Corporate Controller at Marengo, he brings over 15 years of experience in finance and accounting within both public and private biotechnology companies. Chris joined Marengo from Kymera Therapeutics, where he served as Corporate Controller, following a successful career progression at Syros, OvaScience, and Agenus. He began his career in public accounting at Deloitte & Touche, supporting clients in biotechnology, consumer, and industrial products industries. A trusted and respected leader, Chris is pivotal in driving financial strategy and operational excellence at Marengo.